Acid-base balance and substitution fluid during continuous hemofiltration  by Heering, Peter et al.
Kidney International, Vol. 56, Suppl. 72 (1999), pp. S-37–S-40
Acid-base balance and substitution fluid during
continuous hemofiltration
PETER HEERING, KATRIN IVENS, OLIVER THU¨MER, MATTHIAS BRAU¨SE, and BERND GRABENSEE
Department of Nephrology, Heinrich-Heine-University of Du¨sseldorf, Du¨sseldorf, Germany
Acid-base balance during continuous hemofiltration in patients CRRT. Acetate- and lactate-based physiological solu-
with acute renal failure. Critically ill patients with acute renal tions have the advantage of being commercially avail-
failure usually present with an unstable acid-base balance, often able. Under normal conditions, acetate and lactate areleading to cardiovascular complications and multi-organ fail-
metabolized rapidly to bicarbonate. In addition, the ad-ure. Therefore, to prevent metabolic acidosis, acid-base bal-
ministration of large amounts of lactate may result inance must be normalized and maintained; these patients are
primarily treated with continuous hemofiltration techniques increased urea generation (abstract; Olbricht et al, Int
using different replacement fluids to influence the acid-base Soc Blood Purif 10:48, 1992). Bicarbonate has the major
values. Dialysate solutions can be an acetate-based, lactate-
advantage of being the most physiologic anion. Unfortu-based, citrate-based or bicarbonate-based buffer. This article
nately, the production of a commercially available bicar-discusses the strengths and weaknesses of each type of hemofil-
tration replacement fluid. bonate-based physiologic solution is difficult because of
the loss of bicarbonate from the solution or the formation
of calcium and magnesium salts. Persistent acidosis has
Acute renal failure (ARF) complicating the course of been demonstrated to be an indicator of poor prognosis
critical illness continues to be associated with a high [3]. Acetate, as well as lactate, must be metabolized in
mortality, despite many advances made over the last the organism in order to compensate for the loss of
decades in the care of the critically ill patients. The ma- endogenous bicarbonate. Acetate is converted on a 1:1
jority of these patients suffer from multiple- rather than basis to bicarbonate by both the liver and skeletal muscle.
single-organ failure. Continuous venovenous hemofil- Lactate is converted in the liver on a 1:1 basis to bicar-
tration (CVVH) has become common as a renal replace- bonate, and each type of anion is capable of providing
ment therapy, which is often better tolerated than inter- an alkali load sufficient to correct the acidemia of ARF.
mittent hemodialysis at facilitating extracellular fluid Previous studies have suggested that the metabolism of
volume control and reducing cardiovascular disturbances acetate and lactate was impaired in critical illness and
[1, 2]. During continuous renal replacement therapies might be able to produce acidosis [2, 4]. Furthermore,
(CRRTs), alkali administration, either in the replace- it was suggested that lactate and acetate might act as a
ment fluid or by diffusive uptake from the dialysate, must cardiovascular depressant [4]. The correction of meta-
replace not only the bicarbonate lost in the buffering of bolic acidosis is a primary aim for renal replacement
endogenous acid production, but also the bicarbonate therapy. Depending on the type of dialytic modality em-
lost across the hemodiafilter. In most patients with ARF, ployed, the buffer balance is influenced by several fac-
a buffer concentration of approximately 30 to 35 mmol/ tors; among those, the type of buffer employed influences
liter and an ultrafiltration rate (or dialysate flow rate) not only acid-base correction, but possibly also clinical
approaching or exceeding 1 liter/hr can be expected to outcomes. In this brief review, the importance of differ-
normalize the acid-base status within one or two days. ent buffers applied is reviewed under the topic of ARF
In individuals with ARF and lactic acidemia, the buffer in intensive care medicine.
load may need to approach $50 mmol/liter to correct
the associated metabolic acidemia. Acetate, bicarbonate,
citrate, and lactate are the possible choices for bicarbon- DIALYTIC TECHNIQUES
ate or bicarbonate-equivalent administration during The buffer balance depends on buffer losses with ultra-
filtrate and buffer gain with replacement fluid. When
continuous venous-venous hemofiltration is applied toKey words: critical care, multi-organ failure, metabolic acidemia, acido-
sis, dialysate buffer. reduce the patient’s fluid overload, huge volumes of bi-
carbonate are lost and this bicarbonate loss has to be 1999 by the International Society of Nephrology
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replaced. When metabolic acidosis needs to be corrected,
the amount of buffer in the replacement fluid must ex-
ceed the amount lost in ultrafiltrate, thus providing a
positive balance of buffer. Several observations have
reported that the loss of bicarbonate in the ultrafiltrate
exceeds that of plasma so that a sieving coefficient of
higher than 1 can be calculated (between 1.1 and 1.25)
[5]. Because of their greater stability compared with bi-
carbonate, acetate or lactate is used in the buffer of
commercial fluids. The natural buffer, bicarbonate, pre-
cipitates as an insoluble salt when sterilized together
with divalent cations, calcium, and magnesium. Recent
Fig. 1. Plasma bicarbonate levels in patients treated with lactate ( ),technological advances have enabled this problem to be
acetate (h) or bicarbonate (j) based buffer in continuous venous-
overcome. A double chamber bag with two separate venous hemofiltration (CVVH). (Data are from: abstract; Heering et
al, J Am Soc Nephrol 8:159, 1997).compartments, one containing bicarbonate and the other
calcium and magnesium, allows the bicarbonate solution
to be sterilized and stored. Bicarbonate is the most physi-
ologic of the possible anions available for use in CRRT.
and had a presumably higher protein catabolic rate (ab-Based on our experience and that of other investigators,
stract; Olbricht et al, Int Soc Blood Purif 10:48, 1992).normalization of the acid-base balance in patients with
The use of lactate-based hemofiltration/hemodiafiltra-metabolic acidemia resulting only from ARF can be ac-
tion solutions is generally well tolerated in most patientscomplished within 24 to 48 hours using these rates of
undergoing continuous therapies. Most commerciallybicarbonate gain.
available solutions are buffered with approximately 40 to
45 mmol/liter of lactate. The resulting exogenous lactate
CLINICAL FINDINGS load is capable of being cleared by the liver even in the
setting of fulminant hepatic failure. However, there areFew clinical studies have been performed in critically
complications that may arise from the use of lactate-ill patients treated with CVVH in order to assess the
based replacement fluids in critically ill patients. Theefficacy of acidosis correction and to compare the differ-
administration of large amounts of lactate without itsently buffered replacement solutions. However, a great
redox partner pyruvate can possibly result in an in-deal of information could be derived from the treatment
creased protein catabolic rate and myocardial depres-of chronic patients or from intermittent treatments of
sion. The administration of lactate in patients with severecritically ill patients. The effect on acid-base status de-
hypoxia, liver impairment, or pre-existing lactic acidemiapends on the buffer concentration in the fluid and on
can result in a worsening of lactic acidemia. In criticallythe type of buffer used. In general, each type of anion
ill patients with shock and liver failure, the use of lactate-is capable of providing an alkali load sufficient to correct
based fluids in CRRTs may be associated with a paradox-the acidemia of ARF.
ical worsening of acid-base balance. If lactate-based flu-However, there are clinical conditions that might in-
ids are to be used in these individuals, close attention tofluence the clinician’s decision to chose a particular
the patient’s catabolic rate, acid-base status, and arterialbuffer. Hyperacetatemia has a peripheral vasodilating
lactate levels may be necessary. If hemodynamic instabil-effect and a myocardial depressant effect and is able
ity worsens, an assessment of myocardial function and—ifto increase oxygen consumption as a result of acetate
indicated—inotropic support may be appropriate. In ad-metabolism [4]. In a recent study on critically ill patients
dition, serial measurements of the serum anion gap maytreated with CVVH and a 35 mmol/liter acetate replace-
be necessary to detect the accumulation of d-lactate,ment solution, no substantial increase in blood bicarbon-
which is not measured by standard laboratory methodol-ate concentration was recorded (Fig. 1) (abstract; Heer-
ogy. Continuous lactate-based buffer is still the treat-ing et al, J Am Soc Nephrol 8:159, 1997). In this study,
ment of choice. The exceptions are impairment of liverthe correction of metabolic acidosis occurred much more
function and lactic acidosis [2].rapidly and completely in patients who were treated with
When oxidizable anions are used in the replacementCVVH and lactate- or bicarbonate-based replacement
fluids, the anion (acetate or lactate) must be completelytherapy. Lactate is a powerful peripheral vasodilator,
oxidized to CO2 and H2O in order to generate an equimo-affects myocardial contractility, and reduces blood pres-
lar amount of bicarbonate. If the metabolic conversion ofsure. It has been demonstrated that the use of lactate-
nonbicarbonate anions proceeds without accumulation,buffered replacement solution was associated with a
higher serum urea concentration and urea generation the buffering capacity of them is equal to that of bicar-
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One goal of CRRT is to maintain normal acid-base
balance in patients with ARF, thereby preventing the
detrimental effects of acidemia on cardiovascular perfor-
mance. Studies on acetate-based dialysates have shown
undesirable metabolic side-effects such as hypotensive
episodes resulting from the conversion of sodium acetate
to sodium bicarbonate [7]. Meanwhile, some studies have
shown that nonsurvivors remain more acidotic (abstract;
Heering et al, J Am Soc Nephrol 8:159, 1997) [8, 9]. It
has been suggested that nonsurvivors have a decreased
ability to correct metabolic acidosis [10]. The fact that
bicarbonate did not significantly improve these acid-
based disturbances supports the evidence that this mightFig. 2. Plasma bicarbonate levels in patients treated with lactate (h)
be due to processes other than a defect in lactate metabo-or bicarbonate ( ) based buffer in CVVH. (Data are from: abstract;
Riegel et al, J Am Soc Nephrol 8:170A, 1997). lism.
Lactate-based replacement fluids are also associated
with untoward effects [6], but are reported to cause fewer
dialysis related symptoms, including hypotension. Lac-
bonate. Thus, the effect on acid-base status depends on tate and acetate buffers, in particular, have been shown
the buffer concentration in the fluid rather than on the to exert a negative influence on the mean arterial blood
kind of buffer used. When the metabolic conversion is pressure and cardiac function [4]. The problems of wors-
impaired (for example, a hyperlactatemia could occur in ening lactic acidemia in patients with severe circulatory
patients with an associated liver disease who were failure and hepatic dysfunction who are hemofiltered
treated with a lactate-buffered replacement solution) [6], using the commercially available lactate-buffered replace-
the increase blood concentration of the anion leads to ment fluids are now well recognized [11]. An increase in
increase losses of this anion across the dialytic mem- carbon dioxide production is an inevitable consequence
brane, thus reducing the buffer gain. of the correction of lactic acidosis by bicarbonate-buffered
Similar results were reported after the use of bicarbon- hemofiltration, and particular attention should be paid
ate (abstracts; Heering et al, J Am Soc Nephrol 8:159, to the ventilation of the patient to ensure that the pCO2
1997; Riegel et al, J Am Soc Nephrol 8:170A, 1997). level does not rise [12]. Hyperlactatemia occurred in
Bicarbonate is the physiological buffer for the body sys- all groups, with the lactate group having higher levels
tem. Because of its solubility characteristics, no commer- throughout. Although the lactate levels exceeded normal
cial products have been available until now. Recently, values in most cases, they were not generally associated
the results of a large multicenter study on patients with a negative effect on arterial pH. Previous studies
treated with CVVH and bicarbonate-buffered fluid have of lactate-based hemofiltration and dialysis fluids have
been published. The comparison of a 33.75 mmol/liter reported an accumulation of lactate during treatment [13].
lactate-buffered replacement solution with a new 35 The use of bicarbonate-buffered hemofiltration solu-
mmol/ml bicarbonate fluid demonstrated the efficacy of tions has only been studied scarcely in the literature
the bicarbonate solution with the regards to the acidosis (abstract; Olbricht et al, Int Soc Blood Purif 10:48, 1992)
correction and in the lowered hyperlactatemia (Fig. 2) [8, 9]. This is probably because of the fact that bicarbon-
(abstract; Riegel et al, J Am Soc Nephrol 8:170A, 1997). ate-buffered hemofiltration solution was found to be un-
The actual bicarbonate levels were improved in patients stable and, therefore, is not officially approved, at least
treated with bicarbonate-based buffer as compared with in Germany. An improvement in the prognosis of this
lactate-based buffer. Future studies need to focus on extremely sick group of patients has been described if
further indications. It is expected that the relevance of bicarbonate-buffered replacement fluid is used, although
bicarbonate-based buffer will increase in the future and controversial results have been reported [11, 14].
that the use of this buffer will be able to improve cardio-
vascular hemodynamics and prognosis in these patients.
CONCLUSIONS
There is established evidence that the correction of
DISCUSSION metabolic acidosis is mandatory to the survival of acute
Continuous hemofiltration procedures have been uremic patients and that this correction could be ade-
found to be the method of choice in the treatment of quately accomplished by means of continuous renal re-
critically ill patients with ARF (abstract; Marangoni et placement therapys (CRRTs). Because of continuous
and gentle application, no clinically untoward effectsal, Artif Organs 19:490, 1995).
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